steady state for modified release [Regulatives / Guidelines]

posted by Kelen – Brazil, 2019-09-20 22:04 (1906 d 20:32 ago) – Posting: # 20636
Views: 6,208

I would like to ask help for understand the objetive of the steady state study when you are comparing a MR formulation with a IR formulation. The objective would be compare the effect of the accumulation? Is there any reason to conduct the study only with de highest dose?


Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,335 posts in 4,901 threads, 1,665 registered users;
36 visitors (0 registered, 36 guests [including 9 identified bots]).
Forum time: 17:36 CET (Europe/Vienna)

Genius is that which forces
the inertia of humanity to learn.    Henri Bergson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5